NCT00575302View on ClinicalTrials.gov

Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age

PHASE4WithdrawnINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Infertility
Interventions
DRUG

Gonal-f®: follitropin alpha

Gonal-f®: follitropin alpha, administration of 300 U

DRUG

Gonal-f®: follitropin alpha

Gonal-f®: follitropin alpha, administration of 450 U

Trial Locations (4)

1000

CHU Saint-Pierre, Brussels

1180

IMEC, Brussels

4000

CHC Saint-Vincent, Rocourt

9000

UZ Gent, Ghent

Sponsors

Collaborators (1)

EMD Serono
All Listed Sponsors
collaborator

EMD Serono

INDUSTRY

lead

Centre Hospitalier Chretien

OTHER

NCT00575302 - Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age | Biotech Hunter | Biotech Hunter